Purpose
to develop an anti-SARS-CoV-2 mAb product for prevention of severe COVID-19 in vulnerable populations in low and middle income countries
Grantee
Division
Global Health
Date
OCTOBER 2020
Region served
GLOBAL
Committed amount
$223,307
Grant topic
Discovery and Translational Sciences
Duration (months)
13
Grantee location
Amsterdam, Netherlands
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.